Loading
Latest filing published 07 Aug 2026 for Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.), €28k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Tony Blair is a declared insider of Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.), with filings sourced from SEDI. Over a trading history stretching from 13 June 2022 to 5 August 2026, the count stands at 8 filings.
Every open-market trade on record is a purchase: 6 purchases worth €58k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 option exercise.
Half of the purchases are above €11k and half below. None of the 4 purchases we analysed coincided with buying by another insider of the same company within 30 days.
On 7 August 2026 came the latest disclosure, an option exercise for €28k in Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.). The last purchase on record was published on 21 May 2025, which is 521 days ago. Typically, a trade is published a median of 1 day after it takes place. Until a filing is published, the market cannot know about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration